Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ‘superbug’ with a mortality rate that can be upwards of 50% ...
The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...
A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug ...
But now, researchers are exploring promising new treatment strategies, with the aim of making those resistant bacteria susceptible to drugs once more. The rise of antibiotic-resistant bacteria has ...
Antibiotic resistance is the ability of bacteria to resist the effects of antibiotics, a type of drug - such as penicillin or ciprofloxacin - that kills or stops the growth of bacteria. When bacteria ...
They screened minocycline in combination with more than 1,000 previously approved bioactive drug compounds -- most of which had no known antibiotic function -- against three common and often resistant ...